Abstract 4994: Association of protein inhibitor of activated STAT protein 4 with the development of pancreatic ductal adenocarcinoma identified by chromosomal analysis from single nucleotide polymorphism arrays

Wenwen Chien,Norihiko Kawamata,Kazu Okemoto,Seishi Ogawa,H. Phillip Koeffler

DOI: https://doi.org/10.1158/1538-7445.am10-4994

2010-04-15

Cellular and Molecular Biology

Abstract:Abstract The purpose of this study is to identify novel genomic alterations in pancreatic ductal adenocarcinoma (PDAC) by single nucleotide polymorphism arrays (SNP-chip). Genomic DNA from 12 tissues and 15 cell lines of PDAC was examined using 250K SNP-chip. Regions with gains and losses of DNA copy number and loss of heterozygosity (LOH) were identified. Additional 10 normal and 6 tumor samples were used in quantitative real-time PCR to validate a subset of genes in the region with copy number alterations. Our results were compared with previously reported data. Frequent gains of chromosomes: 1q, 2, 3q, 5, 7, 8q, 11, 12p, 14, 17q and 20q (>50% of cases) and losses of 8p, 9p and 18q (>33% of cases) were detected. LOH regions were identified in chromosome arms: 6p, 6q, 8p, 9p, 9q, 13q, 17p, 18q, 19p, 19q and 21q (>25% of cases). On 19p LOH region, a common deletion occurred at 19p13 which included the gene known as protein inhibitor of activated STAT protein 4 (PIAS4). The deletion of the gene and expression levels of PIAS4 were correlated in the PDAC samples. The effects of exogenous over-expression of PIAS4 and short hairpin RNA (shRNA)-mediated knockdown of endogenous PIAS4 on cell proliferation and apoptosis were examined, as well as identification of cell signaling pathway linking PIAS4 and pancreatic tumorigenesis. Over-expression of PIAS4 decreased pancreatic cancer cell growth as well as decreased expression of genes involved in cell proliferation such as Bcl-2, Bcl-xL, cyclin D1 and XIAP. Activated PIAS4 decreased glycogen synthase kinase 3beta (GSK3beta) activity and inhibited transcriptional activity of nuclear factor kappa B (NFkB). Our data indicated that deletion of PIAS4 is associated with development of PDAC. Mechanistic studies showed that PIAS4 acted as a tumor suppressor gene and was a novel modulator of GSK3beta signaling in pancreatic tumorigenesis. Note: This abstract was not presented at the AACR 101st Annual Meeting 2010 because the presenter was unable to attend. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 4994.

cell biology,biochemistry & molecular biology